These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Medicare program; competitive acquisition of outpatient drugs and biologicals under Part B. Interim final rule with comment period.
    Author: Centers for Medicare & Medicaid Services (CMS), HHS.
    Journal: Fed Regist; 2005 Jul 06; 70(128):39021-102. PubMed ID: 15999432.
    Abstract:
    This interim final rule with comment period implements provisions of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 that require the implementation of a competitive acquisition program for certain Medicare Part B drugs not paid on a cost or prospective payment system basis. Beginning January 1, 2006, physicians will generally be given a choice between obtaining these drugs from vendors selected through a competitive bidding process or directly purchasing these drugs and being paid under the average sales price system.
    [Abstract] [Full Text] [Related] [New Search]